{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T10:30:06Z","timestamp":1794738606575,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.vaccine.2023.05.036","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T06:35:47Z","timestamp":1685601347000},"page":"4144-4150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oral and fecal polio vaccine excretion following bOPV vaccination among Israeli infants"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8968-0732","authenticated-orcid":false,"given":"Odelia","family":"Chorin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal Perry","family":"Markovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1217-086X","authenticated-orcid":false,"given":"Eva","family":"Avramovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danit","family":"Sofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamy","family":"Shohat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8791-1162","authenticated-orcid":false,"given":"Ehud","family":"Chorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Tasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Somekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2023.05.036_b0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0168-8510(89)90091-2","article-title":"The 1988 Polio epidemic in Israel: An analysis and consequences","volume":"13","author":"Ellencweig","year":"1989","journal-title":"Health Policy"},{"issue":"38","key":"10.1016\/j.vaccine.2023.05.036_b0010","first-page":"20586","article-title":"Insidious reintroduction of wild poliovirus into Israel, 2013","volume":"18","author":"Anis","year":"2013","journal-title":"Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = Eur Communicable Dis Bull"},{"issue":"11","key":"10.1016\/j.vaccine.2023.05.036_b0015","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/infdis\/jiu674","article-title":"Modeling options to manage type 1 wild poliovirus imported into Israel in 2013","volume":"211","author":"Kalkowska","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.05.036_b0020","first-page":"14","article-title":"Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel","volume":"23","author":"Yaari","year":"2016","journal-title":"BMC Med"},{"issue":"45","key":"10.1016\/j.vaccine.2023.05.036_b0025","doi-asserted-by":"crossref","first-page":"E10625","DOI":"10.1073\/pnas.1808798115","article-title":"Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data","volume":"115","author":"Brouwer","year":"2018","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"10.1016\/j.vaccine.2023.05.036_b0030","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/S1473-3099(15)00064-X","article-title":"The Israeli public health response to wild poliovirus importation","volume":"15","author":"Kaliner","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2023.05.036_b0035","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/14760584.2015.1001750","article-title":"Polio endgame: the global introduction of inactivated polio vaccine","volume":"14","author":"Patel","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"10.1016\/j.vaccine.2023.05.036_b0040","doi-asserted-by":"crossref","first-page":"CD011260","DOI":"10.1002\/14651858.CD011260.pub2","article-title":"Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis","volume":"2019","author":"Ciapponi","year":"2019","journal-title":"Cochrane Database System Rev"},{"key":"10.1016\/j.vaccine.2023.05.036_b0045","first-page":"1","article-title":"Mucosal immunity to poliovirus","author":"Connor","year":"2021","journal-title":"Mucosal Immunology [Internet]"},{"issue":"8","key":"10.1016\/j.vaccine.2023.05.036_b0050","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.vaccine.2007.12.021","article-title":"Intestinal immunity following a combined enhanced inactivated polio vaccine\/oral polio vaccine programme in Israel","volume":"26","author":"Swartz","year":"2008","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2023.05.036_b0055","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.vaccine.2017.04.036","article-title":"Responding to a cVDPV1 outbreak in Ukraine: Implications, challenges and opportunities","volume":"35","author":"Khetsuriani","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.05.036_b0060","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/rmv.401","article-title":"Polio eradication: the OPV paradox","volume":"13","author":"Dowdle","year":"2003","journal-title":"Rev Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.036_b0065","article-title":"The challenges of poliovirus eradication","volume":"3","author":"Yelle","year":"2016","journal-title":"J Human Virol Retrovirol"},{"key":"10.1016\/j.vaccine.2023.05.036_b0070","unstructured":"Circulating vaccine-derived poliovirus type 3 \u2013 Israel [Internet]. www.who.int. [cited 2022 Oct 15]. Available from: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON366."},{"key":"10.1016\/j.vaccine.2023.05.036_b0075","unstructured":"Link-Gelles R. Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater \u2014 New York, June\u2013August 2022. MMWR Morbidity Mortality Weekly Report [Internet] 2022; 71. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7133e2.htm."},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.036_b0080","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/aje\/kwi206","article-title":"A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future","volume":"162","author":"Duintjer Tebbens","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.vaccine.2023.05.036_b0085","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.2105\/AJPH.2007.122192","article-title":"The risks, costs, and benefits of possible future global policies for managing polioviruses","volume":"98","author":"Thompson","year":"2008","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.036_b0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/risa.13557","article-title":"Potential future use, costs, and value of poliovirus vaccines","volume":"41","author":"Thompson","year":"2020","journal-title":"Risk Anal"},{"issue":"Supplement 1","key":"10.1016\/j.vaccine.2023.05.036_b0095","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1093\/infdis\/175.Supplement_1.S176","article-title":"Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: A review of the literature","volume":"175","author":"Alexander","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.05.036_b0100","doi-asserted-by":"crossref","unstructured":"Hird TR, Grassly NC. Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge. Andino R, editor. PLoS Pathogens 2012; 8(4): e1002599.","DOI":"10.1371\/journal.ppat.1002599"},{"issue":"10040","key":"10.1016\/j.vaccine.2023.05.036_b0105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(16)00703-0","article-title":"Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial","volume":"388","author":"Asturias","year":"2016","journal-title":"Lancet"},{"issue":"6199","key":"10.1016\/j.vaccine.2023.05.036_b0110","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1126\/science.1255006","article-title":"Efficacy of inactivated poliovirus vaccine in India","volume":"345","author":"Jafari","year":"2014","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.vaccine.2023.05.036_b0115","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1473-3099(15)00219-4","article-title":"Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study","volume":"15","author":"O\u2019Ryan","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"3209","key":"10.1016\/j.vaccine.2023.05.036_b0120","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.123.3209.1151","article-title":"Pathogenesis of poliomyelitis reappraisal in the light of new data","volume":"123","author":"Sabin","year":"1956","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2023.05.036_b0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1542\/peds.21.3.353","article-title":"Influence of prior active immunization on the presence of poliomyelitis virus in the pharynx and stools of family contacts of patients with paralytic poliomyelitis","volume":"21","author":"Wehrle","year":"1958","journal-title":"Pediatrics"},{"issue":"21","key":"10.1016\/j.vaccine.2023.05.036_b0130","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jama.1996.03530450029028","article-title":"Seroprevalence of antibody against poliovirus in inner-city preschool children","volume":"275","author":"Chen","year":"1996","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.036_b0135","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.102.6.1423","article-title":"Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine","volume":"102","author":"Ogra","year":"1969","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.05.036_b0140","unstructured":"World. Polio Laboratory Manual; 2004."},{"issue":"6","key":"10.1016\/j.vaccine.2023.05.036_b0145","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1128\/JCM.00702-09","article-title":"Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues","volume":"47","author":"Kilpatrick","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2023.05.036_b0150","article-title":"Poliovirus is detected in sewage from north and east London","volume":"23","author":"Wise","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2023.05.036_b0155","doi-asserted-by":"crossref","unstructured":"Zuckerman NS, Bar-Or I, Sofer D, Bucris E, Morad H, Shulman LM, et al. Emergence of genetically linked vaccine-originated poliovirus type 2 in the absence of oral polio vaccine, Jerusalem, April to July 2022. Eurosurveillance 2022; 27(37).","DOI":"10.2807\/1560-7917.ES.2022.27.37.2200694"},{"issue":"suppl_1","key":"10.1016\/j.vaccine.2023.05.036_b0160","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1093\/cid\/ciy603","volume":"67","author":"Brickley","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"52","key":"10.1016\/j.vaccine.2023.05.036_b0165","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1016\/j.vaccine.2017.11.006","article-title":"Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules","volume":"35","author":"Bandyopadhyay","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2023.05.036_b0170","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJM195707112570201","article-title":"Influence of age and sex on susceptibility and clinical manifestations in poliomyelitis","volume":"257","author":"Weinstein","year":"1957","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2023.05.036_b0175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jtbi.2014.09.026","article-title":"Transmission dynamics of oral polio vaccine viruses and vaccine-derived polioviruses on networks","volume":"364","author":"Kim","year":"2015","journal-title":"J Theor Biol"},{"issue":"S1","key":"10.1016\/j.vaccine.2023.05.036_b0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.14745\/ccdr.v41is1a01f","article-title":"R\u00e9sum\u00e9 de la surveillance des cas p\u00e9diatriques d\u2019ent\u00e9rovirus D68 hospitalis\u00e9s au Canada, septembre 2014","volume":"41","author":"Edwin","year":"2015","journal-title":"Relev\u00e9 des maladies transmissibles au Canada"},{"issue":"8","key":"10.1016\/j.vaccine.2023.05.036_b0185","first-page":"1","article-title":"Centers for disease control and prevention. Enterovirus surveillance\u2013United States, 1970\u20132005","volume":"55","author":"Khetsuriani","year":"2006","journal-title":"MMWR Surveill Summ"},{"issue":"42","key":"10.1016\/j.vaccine.2023.05.036_b0190","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.42.20935","article-title":"Continued seasonal circulation of enterovirus D68 in the Netherlands, 2011\u20132014","volume":"19","author":"Meijer","year":"2014","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.vaccine.2023.05.036_b0195","doi-asserted-by":"crossref","unstructured":"Lund N, Andersen A, Hansen ASK, Jepsen FS, Barbosa A, Biering-S\u00f8rensen S, et al. The effect of oral polio vaccine at birth on infant mortality: A randomized trial. Clin Infect Dis: Off Publ Infect Dis Soc Am [Internet] 2015 Nov 15 [cited 2021 Oct 10]; 61(10): 1504\u201311. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26219694\/.","DOI":"10.1093\/cid\/civ617"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.036_b0200","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1539-6924.2012.01864.x","article-title":"Expert review on poliovirus immunity and transmission","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"},{"issue":"4","key":"10.1016\/j.vaccine.2023.05.036_b0205","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/risa.12031","article-title":"Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs","volume":"33","author":"Duintjer Tebbens","year":"2013","journal-title":"Risk Anal"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23005856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23005856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:27:19Z","timestamp":1759404439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23005856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":41,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0264410X23005856"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral and fecal polio vaccine excretion following bOPV vaccination among Israeli infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}